CASI PHARMACEUTICALS, INC. Equity Securities, FV-NI, Gain (Loss)
CASI PHARMACEUTICALS, INC. (CASIF) reported Equity Securities, FV-NI, Gain (Loss) of -$179.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-05-15.
Financial Statements › Income Statement › Other Income
us-gaap:EquitySecuritiesFvNiGainLoss · last filed 2026-05-15
| Period end | Equity Securities, FV-NI, Gain (Loss) 12 month |
|---|---|
| 2025-12-31 | -$179.00K 20-F · filed 2026-05-15 |
| 2024-12-31 | $1.70M 20-F · filed 2026-05-15 |
| 2023-12-31 | -$581.00K 20-F · filed 2026-05-15 |
| 2022-12-31 | -$8.89M 20-F · filed 2025-03-31 |